PSDN News and Press, AdvisorShares Poseidon Dynamic Cannabis ETF

2023-08-29 09:42:30 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips AdvisorShares , the company managing the world’s largest hemp exchange-traded fund Poseidon Dynamic Cannabis ETF (NYSEARCA: PSDN ), has reported a waning interest in ca...

2023-03-29 17:00:00 ET Summary Bengal Capital's Jerry Derevyanny moved away from top multi-state operators (MSOs) to find the most value. Why EBITDA falls short as a useful metric to measure cannabis stocks. 280E tax a dangerous way to underwrite the industry. ...

2023-03-22 17:00:00 ET Summary Ascend Wellness is one of the MSOs that analysts have recently been discussing on Seeking Alpha and championing on this podcast. CFO and interim co-CEO Dan Neville joins us to discuss looking for new leadership and what investors should be looking at...

2023-03-15 17:00:00 ET Summary Pelorus Equity Group's Rob Sechrist shares valuable advice for retail investors in the cannabis space. Scale is not the ultimate driver of cannabis companies. Outliers in California cannabis. Cannabis investing in a deflationary environment. ...

Summary The first ever cannabis investing podcast roundtable discussion! Investing in the cannabis industry: stocks, ETFs and patience. Honestly assess your risk profile. Mistaken assumptions around illicit to legal markets. Confronting synthetic cannabinoids. Excitement ove...

Summary Cannabis ETFs began to hit the market in 2017. As cannabis stocks have declined, they have lost their popularity. I review the small universe and find none that seem worthy of investment. Investors that want to invest in cannabis can do better picking stocks in my view. ...

Summary Cannabis stocks are really cheap, but Alan Brochstein is worried about 3 things. Thoughts on Cresco/Columbia Care deal. Sector debt and optimal cannabis investing metrics. Canadian and US operators. Concerns around MSOS; limitations of ETFs. Why Alan's 19% in cash. ...

Summary Nick Gastevich, aka CannaVestments, one of our favorite commenters on Seeking Alpha, returns for a super actionable take on cannabis stocks. Focus on companies that control their own destinies as much as possible. Which balance sheets are in trouble and who's generating real...

Summary InterCure earned CAD$39 million in Q3 2022, up 61.2% from the previous year. Moreover, at the end of Q4 2022, the total number of licensed patients using cannabis for medical purposes in Israel was 123,212, up 13,860 from the previous year. Currently, the cannabis industry c...

Summary The most consistent progress in cannabis is coming from states continuing to roll out legalization programs. For cannabis companies wanting to make a profit in these legal markets, there is both opportunity and a need to navigate growing pains. A reminder from Tim Seymo...